December 06, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Biotechnology

Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


On January 23, the Subcommittee on Intellectual Property held a hearing in which the members of the committee heard testimony about the Patent Eligibility Restoration Act (PERA) introduced by Senators Coons and Tillis. I have considered case law directed to s. 101 of 25 U.S.C. for more than a decade, and was hopeful that PERA could achieve its subtitled goal of “Restoring Clarity, Certainty, and Predictability to the U.S. Patent System”. The eight panelists had submitted comments that preceded the hearing, and the hearing was live streamed. The panelists were a blue ribbon group of patent attorneys who testified before the…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

EPA’s Final Rule on TCE: Regulatory Freeze and Further Delays

Environmental Science
April 5, 2025

Flow Cytometry: A Buyer's Guide

The flow cytometry landscape is rapidly expanding, with platforms ranging from standard benchtop analyzers to…

December 6, 2025

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

The Future of Marketing in the Biotechnology Industry: The Role of Press Release Distribution

The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…

Biotechnology
April 9, 2025

Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers

On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped…

Biotechnology
April 5, 2025

Federal Circuit Revolutionizes Country of Origin Analysis for Pharmaceuticals

The Federal Circuit Court of Appeals has just rejected the longstanding U.S. government position that the country of origin of…

Biotechnology
April 5, 2025

Regeneron v. Mylan, “It Ain’t Necessarily So.” |

Regeneron v. Mylan, appeal nos. 2024-2058, 2024-2147 (Fed. Cir., March 5, 2025) is the most recent appeal in a long…

Biotechnology
May 23, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Flow Cytometry: A Buyer's Guide
December 6, 2025
Studying The Effects Of Drugs On Driving
December 5, 2025
BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
December 5, 2025
منصة BingX تطلق ميزة الشراء المتكرر لمساعدة المستخدمين على مواجهة تقلبات سوق العملات الرقمية
December 5, 2025

Life Science Magazines

Flow Cytometry: A Buyer's Guide
December 6, 2025
Studying The Effects Of Drugs On Driving
December 5, 2025
Human Abuse Potential Studies
December 5, 2025
Connecting for quality: Powering cGMP for cell and gene…
December 5, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?